Summit Therapeutics SMMT Comprehensive Income (Loss), Net of Tax, Attributable to Parent
Comprehensive Income (Loss), Net of Tax, Attributable to Parent at other companies
Other financials
Where this comes from
Reported directly by Summit Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:ComprehensiveIncomeNetOfTax.
The official record: Summit Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Summit Therapeutics's comprehensive income (loss), net of tax, attributable to parent.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Summit Therapeutics's comprehensive income (loss), net of tax, attributable to parent?
- Summit Therapeutics (SMMT) reported comprehensive income (loss), net of tax, attributable to parent of -$189.52M in Q1 2026.
- How has Summit Therapeutics's comprehensive income (loss), net of tax, attributable to parent changed year-over-year?
- Summit Therapeutics's comprehensive income (loss), net of tax, attributable to parent decreased by 199.9% year-over-year, from -$63.19M to -$189.52M.
- What is the long-term trend for Summit Therapeutics's comprehensive income (loss), net of tax, attributable to parent?
- Over 4 years (2021 to 2025), Summit Therapeutics's comprehensive income (loss), net of tax, attributable to parent has grown at a 87.7% compound annual growth rate (CAGR), from -$87.01M to -$1.08B.
- What does comprehensive income (loss), net of tax, attributable to parent mean?
- The total financial performance of the company including both standard profit and other non-operating gains or losses.
- How do you interpret comprehensive income (loss), net of tax, attributable to parent?
- An increase indicates overall growth in the company's net worth, while a decrease indicates a contraction in total equity.
- How does comprehensive income (loss), net of tax, attributable to parent compare across companies?
- A standard GAAP metric used by all public companies to show total economic performance; investors compare this to net income to identify non-operating volatility.